For the 1.5 million women in the UK living with endometriosis, relief may finally be on the horizon. A new pill, relugolix–estradiol–norethisterone (also known as Ryeqo), has been approved for NHS use ...

Endometriosis UK believes that women and those assigned female at birth in the UK should be able to choose the right treatment and management options for them. ‘W ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales - but only ...

Endometriosis affects approximately 1.5 million women in the UK, leading to chronic pain and fatigue as tissue similar to the ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative option if treatments such as tranexamic acid, hormonal contraceptives, and ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute to endometriosis, while also providing necessary hormone replacement ...

Women’s health experts issue warning on limitations of ‘miracle’ endometriosis pill - Debilitating condition affects around 1 ...

A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved by the National Institue for Health and Care Excellence (NICE) for use on ...

A 'first-of-a-kind' daily pill for endometriosis has been approved by NHS England. But how effective is it, how does it work and what do the studies say?

The world’s first pill for endometriosis has been approved for NHS use, providing hope for people in the UK suffering from the painful condition. Endometriosis is notoriously understudied and ...